Literature DB >> 22482801

Fragile X and X-linked intellectual disability: four decades of discovery.

Herbert A Lubs1, Roger E Stevenson, Charles E Schwartz.   

Abstract

X-Linked intellectual disability (XLID) accounts for 5%-10% of intellectual disability in males. Over 150 syndromes, the most common of which is the fragile X syndrome, have been described. A large number of families with nonsyndromal XLID, 95 of which have been regionally mapped, have been described as well. Mutations in 102 X-linked genes have been associated with 81 of these XLID syndromes and with 35 of the regionally mapped families with nonsyndromal XLID. Identification of these genes has enabled considerable reclassification and better understanding of the biological basis of XLID. At the same time, it has improved the clinical diagnosis of XLID and allowed for carrier detection and prevention strategies through gamete donation, prenatal diagnosis, and genetic counseling. Progress in delineating XLID has far outpaced the efforts to understand the genetic basis for autosomal intellectual disability. In large measure, this has been because of the relative ease of identifying families with XLID and finding the responsible mutations, as well as the determined and interactive efforts of a small group of researchers worldwide.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22482801      PMCID: PMC3322227          DOI: 10.1016/j.ajhg.2012.02.018

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  106 in total

1.  XLMR genes: update 1990.

Authors:  G Neri; F Gurrieri; A Gal; H A Lubs
Journal:  Am J Med Genet       Date:  1991 Feb-Mar

Review 2.  Genetics of intellectual disability.

Authors:  H Hilger Ropers
Journal:  Curr Opin Genet Dev       Date:  2008-08-28       Impact factor: 5.578

3.  Intelligence and the X chromosome.

Authors:  G Turner
Journal:  Lancet       Date:  1996-06-29       Impact factor: 79.321

4.  Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy.

Authors:  Petter Strømme; Marie E Mangelsdorf; Marie A Shaw; Karen M Lower; Suzanne M E Lewis; Helene Bruyere; Viggo Lütcherath; Agi K Gedeon; Robyn H Wallace; Ingrid E Scheffer; Gillian Turner; Michael Partington; Suzanna G M Frints; Jean-Pierre Fryns; Grant R Sutherland; John C Mulley; Jozef Gécz
Journal:  Nat Genet       Date:  2002-03-11       Impact factor: 38.330

5.  The fragile X: a scanning electron microscope study.

Authors:  C J Harrison; E M Jack; T D Allen; R Harris
Journal:  J Med Genet       Date:  1983-08       Impact factor: 6.318

6.  A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome.

Authors:  Hiba Risheg; John M Graham; Robin D Clark; R Curtis Rogers; John M Opitz; John B Moeschler; Andreas P Peiffer; Melanie May; Sumy M Joseph; Julie R Jones; Roger E Stevenson; Charles E Schwartz; Michael J Friez
Journal:  Nat Genet       Date:  2007-03-04       Impact factor: 38.330

7.  Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28.

Authors:  Michael J Friez; Julie R Jones; Katie Clarkson; Herbert Lubs; Dianne Abuelo; Jo-Ann Blaymore Bier; Shashidhar Pai; Richard Simensen; Charles Williams; Philip F Giampietro; Charles E Schwartz; Roger E Stevenson
Journal:  Pediatrics       Date:  2006-11-06       Impact factor: 7.124

8.  Infantile spasms, dystonia, and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, ARX.

Authors:  Petter Strømme; Marie E Mangelsdorf; Ingrid E Scheffer; Jozef Gécz
Journal:  Brain Dev       Date:  2002-08       Impact factor: 1.961

9.  ARX mutations in X-linked lissencephaly with abnormal genitalia.

Authors:  G Uyanik; L Aigner; P Martin; C Gross; D Neumann; H Marschner-Schäfer; U Hehr; J Winkler
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

10.  BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.

Authors:  Christopher A French; Isao Miyoshi; Ichiro Kubonishi; Holcombe E Grier; Antonio R Perez-Atayde; Jonathan A Fletcher
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

View more
  76 in total

Review 1.  Genetic studies in intellectual disability and related disorders.

Authors:  Lisenka E L M Vissers; Christian Gilissen; Joris A Veltman
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

2.  XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing.

Authors:  Amélie Piton; Claire Redin; Jean-Louis Mandel
Journal:  Am J Hum Genet       Date:  2013-07-18       Impact factor: 11.025

3.  Next-generation sequencing in X-linked intellectual disability.

Authors:  Andreas Tzschach; Ute Grasshoff; Stefanie Beck-Woedl; Claudia Dufke; Claudia Bauer; Martin Kehrer; Christina Evers; Ute Moog; Barbara Oehl-Jaschkowitz; Nataliya Di Donato; Robert Maiwald; Christine Jung; Alma Kuechler; Solveig Schulz; Peter Meinecke; Stephanie Spranger; Jürgen Kohlhase; Jörg Seidel; Silke Reif; Manuela Rieger; Angelika Riess; Marc Sturm; Julia Bickmann; Christopher Schroeder; Andreas Dufke; Olaf Riess; Peter Bauer
Journal:  Eur J Hum Genet       Date:  2015-02-04       Impact factor: 4.246

4.  Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system.

Authors:  A S Cristino; S M Williams; Z Hawi; J-Y An; M A Bellgrove; C E Schwartz; L da F Costa; C Claudianos
Journal:  Mol Psychiatry       Date:  2013-02-26       Impact factor: 15.992

5.  Disease gene prioritization using network and feature.

Authors:  Bingqing Xie; Gady Agam; Sandhya Balasubramanian; Jinbo Xu; T Conrad Gilliam; Natalia Maltsev; Daniela Börnigen
Journal:  J Comput Biol       Date:  2015-04       Impact factor: 1.479

6.  An X-linked channelopathy with cardiomegaly due to a CLIC2 mutation enhancing ryanodine receptor channel activity.

Authors:  Kyoko Takano; Dan Liu; Patrick Tarpey; Esther Gallant; Alex Lam; Shawn Witham; Emil Alexov; Alka Chaubey; Roger E Stevenson; Charles E Schwartz; Philip G Board; Angela F Dulhunty
Journal:  Hum Mol Genet       Date:  2012-07-19       Impact factor: 6.150

Review 7.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

8.  Functional characterization of CDK5 and CDK5R1 mutations identified in patients with non-syndromic intellectual disability.

Authors:  Silvia Moncini; Paola Castronovo; Alessandra Murgia; Silvia Russo; Maria Francesca Bedeschi; Marta Lunghi; Angelo Selicorni; Maria Teresa Bonati; Paola Riva; Marco Venturin
Journal:  J Hum Genet       Date:  2015-12-10       Impact factor: 3.172

9.  5'-UTR SNP of FGF13 causes translational defect and intellectual disability.

Authors:  Xingyu Pan; Jingrong Zhao; Zhiying Zhou; Jijun Chen; Zhenxing Yang; Yuxuan Wu; Meizhu Bai; Yang Jiao; Yun Yang; Xuye Hu; Tianling Cheng; Qianyun Lu; Bin Wang; Chang-Lin Li; Ying-Jin Lu; Lei Diao; Yan-Qing Zhong; Jing Pan; Jianmin Zhu; Hua-Sheng Xiao; Zi-Long Qiu; Jinsong Li; Zefeng Wang; Jingyi Hui; Lan Bao; Xu Zhang
Journal:  Elife       Date:  2021-06-29       Impact factor: 8.140

10.  A quantitative framework to evaluate modeling of cortical development by neural stem cells.

Authors:  Jason L Stein; Luis de la Torre-Ubieta; Yuan Tian; Neelroop N Parikshak; Israel A Hernández; Maria C Marchetto; Dylan K Baker; Daning Lu; Cassidy R Hinman; Jennifer K Lowe; Eric M Wexler; Alysson R Muotri; Fred H Gage; Kenneth S Kosik; Daniel H Geschwind
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.